WordNet

relating to or having the characteristics of a family; "children of the same familial background"; "familial aggregation"
occurring among members of a family usually by heredity; "an inherited disease"; "familial traits"; "genetically transmitted features" (同)genetic, hereditary, inherited, transmitted, transmissible
type genus of the family Cancridae (同)genus Cancer
the fourth sign of the zodiac; the sun is in this sign from about June 21 to July 22 (同)Cancer the Crab, Crab
(astrology) a person who is born while the sun is in Cancer (同)Crab
a small zodiacal constellation in the northern hemisphere; between Leo and Gemini
any malignant growth or tumor caused by abnormal and uncontrolled cell division; it may spread to other parts of the body through the lymphatic system or the blood stream (同)malignant neoplastic disease

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men.

Cartwright R1, Mangera A2, Tikkinen KA3, Rajan P4, Pesonen J5, Kirby AC6, Thiagamoorthy G7, Ambrose C8, Gonzalez-Maffe J9, Bennett PR10, Palmer T11, Walley A12, Järvelin MR13, Khullar V14, Chapple C15.
European urology.Eur Urol.2014 Oct;66(4):752-768. doi: 10.1016/j.eururo.2014.01.007. Epub 2014 Jan 22.
CONTEXT: Although family studies have shown that male lower urinary tract symptoms (LUTS) are highly heritable, no systematic review exists of genetic polymorphisms tested for association with LUTS.OBJECTIVE: To systematically review and meta-analyze studies assessing candidate polymorphisms/genes t
PMID 24491308

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.

Fong L1, Carroll P2, Weinberg V2, Chan S2, Lewis J2, Corman J2, Amling CL2, Stephenson RA2, Simko J2, Sheikh NA2, Sims RB2, Frohlich MW2, Small EJ2.
Journal of the National Cancer Institute.J Natl Cancer Inst.2014 Sep 24;106(11). pii: dju268. doi: 10.1093/jnci/dju268. Print 2014 Nov.
BACKGROUND: Sipuleucel-T is a US Food and Drug Administration-approved immunotherapy for asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC). Its mechanism of action is not fully understood. This prospective trial evaluated the direct immune effects of syste
PMID 25255802

Extended Follow-Up and Risk Factors for Disease Reclassification from a Large Active Surveillance Cohort for Localized Prostate Cancer.

Welty CJ1, Cowan JE2, Nguyen H2, Shinohara K2, Perez N2, Greene KL2, Chan JM2, Meng MV2, Simko JP2, Cooperberg MR2, Carroll PR2.
The Journal of urology.J Urol.2014 Sep 24. pii: S0022-5347(14)04547-9. doi: 10.1016/j.juro.2014.09.094. [Epub ahead of print]
INTRODUCTION: The use of active surveillance (AS) to manage prostate cancer (PCa) provides an alternative to immediate treatment for men with low-risk PCa. We report updated outcomes from a long-standing AS cohort and factors associated with reclassification.METHODS: We retrospectively reviewed data
PMID 25261803